Related Experiment Video

Updated: Jun 24, 2026

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform
06:21

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform

Published on: May 10, 2024

Short interfering RNA directed against the E2F-1 gene suppressing gastric cancer progression in vitro

Yubo Xie1, Yongshuo Yin, Lei Li

  • 1Department of Surgery, The First Affiliated Hospital, Guangxi Medical University, Guangxi 530021, PR China.

Oncology Reports
|April 11, 2009
PubMed

Insights

RNA interference targeting E2F-1 effectively inhibits gastric cancer progression. This study demonstrates that E2F-1 siRNA reduces tumor cell proliferation, increases apoptosis, and inhibits migration and invasion in gastric cancer cells.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Therapy

Background:

  • Gastric cancer is a leading cause of cancer-related mortality in China.
  • Sustained overexpression of E2F-1 is a hallmark of gastric cancer.
  • RNA interference (RNAi) offers a potential therapeutic strategy for gene silencing.

Purpose of the Study:

  • To investigate the efficacy of RNA interference targeting E2F-1 in gastric cancer.
  • To evaluate the impact of E2F-1 silencing on gastric cancer cell behavior in vitro.

Main Methods:

  • Construction of recombinant Psilencer 4.1-E2F-1 siRNA plasmids.
  • Transfection of siRNA into human gastric cancer MGC-803 cells.
  • Assessment of E2F-1 mRNA and protein levels using RT-PCR and Western blotting.
  • Evaluation of cell proliferation, apoptosis, migration, and invasion.

Main Results:

  • E2F-1 siRNA significantly inhibited endogenous E2F-1 mRNA and protein expression.
  • Silencing E2F-1 reduced gastric cancer cell proliferation.
  • Increased apoptosis was observed in E2F-1 silenced cells.
  • Inhibition of tumor cell migration and invasion potential was demonstrated.

Conclusions:

  • siRNA targeting E2F-1 effectively suppresses gastric cancer progression.
  • E2F-1 silencing presents a promising therapeutic approach for gastric cancer treatment.

More Related Videos

Combined Conditional Knockdown and Adapted Sphere Formation Assay to Study a Stemness-Associated Gene of Patient-derived Gastric Cancer Stem Cells09:24

Combined Conditional Knockdown and Adapted Sphere Formation Assay to Study a Stemness-Associated Gene of Patient-derived Gastric Cancer Stem Cells

Published on: May 9, 2020

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...